3 Ideas 4 Q2
A second-quarter repeat of the first-quarter rally? Unlikely. But stocks still remain the favored asset class – as long as investors are selective in their… Read More »3 Ideas 4 Q2
Investors
The Best Opportunity Right Now – And Why It’s Being Ignored
The stocks offering the best risk-reward ratio in the market right now are being largely ignored by investors, according to J.P. Morgan. What stocks are… Read More »The Best Opportunity Right Now – And Why It’s Being Ignored
“Safe” Stocks, Disrupted
Investors are willing to pay substantial premiums for stocks perceived to be safe. But in the age of disruption, is there truly such a thing… Read More »“Safe” Stocks, Disrupted
Playing The Esports Boom
The esports industry is booming, with revenues exceeding $860 million last year and expected to reach $1.7 billion by 2022. That makes this exchange traded… Read More »Playing The Esports Boom
From Hope To Reality: The Pot Trade In 2019
If 2018 was the “Year of Hope” for pot stocks, 2019 may be best viewed as the “Year of Reality” – with plenty of opportunities… Read More »From Hope To Reality: The Pot Trade In 2019
How To Profit From Hemp’s New Status
While marijuana remains illegal at the federal level in the U.S., Congress just legalized hemp at the federal level with the passage of the farm… Read More »How To Profit From Hemp’s New Status
Doubling (Or Tripling) Down
What are leveraged (2x or 3x) ETFs and how do you trade them? Here’s a look at what these funds offer, the risks involved –… Read More »Doubling (Or Tripling) Down
Gone To Pot
The dramatic rise and fall of shares of India Globalization Capital – a company that claimed to have cannabis-based treatments for Alzheimer’s, Parkinson’s and other… Read More »Gone To Pot
Tis The Season For Potential Health Care Catalysts
In the final weeks of 2018 (and the final weeks of a GOP-controlled House of Representatives), there are a number of potential legislative catalysts for… Read More »Tis The Season For Potential Health Care Catalysts
The New – And More Effective – Female Viagra: An Attractive Opportunity?
This biotech company’s drug for treating hypoactive sexual desire disorder in women is expected to receive FDA approval in early January 2019. With increasing market… Read More »The New – And More Effective – Female Viagra: An Attractive Opportunity?